Anavex Life Sciences Corp (AVXL)

[sokol]

Chaikin rates AVXL bearish (no surprise), although that does not mean that the stock cannot turn bullish quickly -- especially since it's a startup biotech awaiting an important clinical trial report. Significantly, the Chaikin power gauge report states that insiders are buying. If true, the latter is confirmation of good results that may be reported. The question is when? I keep am telling myself (I talk to myself a lot) that three things are important for my long position at this juncture: 1. Patience 2. Patience, and 3. More patience.